Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Pancreatic Neoplasms × acalabrutinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 27 Lymphoma, Mantle-Cell 12 Lymphoma, Non-Hodgkin 6 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma 4 Leukemia, B-Cell 3 Waldenstrom Macroglobulinemia 2 Recurrence 2 Multiple Myeloma 2 Lymphoma, Follicular 2 Lymphoma, B-Cell 2 Leukemia, Prolymphocytic 2 Leukemia 2 Squamous Cell Carcinoma of Head and Neck 1 Part1: Advanced B-cell Malignancies 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphatic Diseases 1 Leukemia, Hairy Cell 1 Immunoproliferative Disorders 1 Immune System Diseases 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Heart Failure 1 Glioblastoma 1 DLBCL 1 Chromosome 17 deletion 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 182 130-nm albumin-bound paclitaxel 71 Albumin-Bound Paclitaxel 50 pembrolizumab 37 Fluorouracil 37 Leucovorin 30 Oxaliplatin 29 Capecitabine 22 Nivolumab 20 Irinotecan 17 Paclitaxel 15 Bevacizumab 15 Cetuximab 13 Erlotinib Hydrochloride 12 Cyclophosphamide 12 Taxes 11 Carboplatin 11 irinotecan sucrosofate 10 Drug Therapy 10 Injections 9 Cisplatin 9 spartalizumab 7 olaparib 6 fludarabine 6 TH 302 6 Pemetrexed 6 Docetaxel 6 ALT-803 6 avelumab 5 Ipilimumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02362048 2019-10-01

KEYNOTE144

Acerta Pharma BV

Phase 2 Completed

77 enrolled 11 charts

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡